Modeling proteasome dynamics in Parkinson's disease
暂无分享,去创建一个
Kim Sneppen | Simone Pigolotti | Ludvig Lizana | Mogens H Jensen | Daniel Otzen | M. Jensen | K. Sneppen | D. Otzen | L. Lizana | S. Pigolotti
[1] R. Sandri-Goldin,et al. ICP27 Interacts with the C-Terminal Domain of RNA Polymerase II and Facilitates Its Recruitment to Herpes Simplex Virus 1 Transcription Sites, Where It Undergoes Proteasomal Degradation during Infection , 2006, Journal of Virology.
[2] Y. Murakami,et al. Hybrid Proteasomes , 2000, The Journal of Biological Chemistry.
[3] Kim Sneppen,et al. Quantifying the benefits of translation regulation in the unfolded protein response , 2004, Physical biology.
[4] K. Davies,et al. Proteasome inhibition by lipofuscin/ceroid during postmitotic aging of fibroblasts , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[5] M. Briand,et al. Linkage between the proteasome pathway and neurodegenerative diseases and aging , 2004, Molecular Neurobiology.
[6] K. Sneppen,et al. Oscillations and temporal signalling in cells , 2007, Physical biology.
[7] T. Reinheckel,et al. Degradation of oxidized proteins in mammalian cells , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[8] Shubo Han,et al. The Flavonoid Baicalein Inhibits Fibrillation of α-Synuclein and Disaggregates Existing Fibrils* , 2004, Journal of Biological Chemistry.
[9] M. L. Schmidt,et al. α-Synuclein in Lewy bodies , 1997, Nature.
[10] Jean-Christophe Rochet,et al. Interactions among alpha-synuclein, dopamine, and biomembranes: some clues for understanding neurodegeneration in Parkinson's disease. , 2004, Journal of molecular neuroscience : MN.
[11] P. Lansbury,et al. Is there a cause-and-effect relationship between α-synuclein fibrillization and Parkinson’s disease? , 2000, Nature Cell Biology.
[12] Daniel Offen,et al. Proteasomal inhibition hypersensitizes differentiated neuroblastoma cells to oxidative damage , 2006, Neuroscience Letters.
[13] T. Chase,et al. Degradation of α-Synuclein by Proteasome* , 1999, The Journal of Biological Chemistry.
[14] Min Zhu,et al. Alpha-synuclein can function as an antioxidant preventing oxidation of unsaturated lipid in vesicles. , 2006, Biochemistry.
[15] Y. Imai,et al. Parkin Suppresses Unfolded Protein Stress-induced Cell Death through Its E3 Ubiquitin-protein Ligase Activity* , 2000, The Journal of Biological Chemistry.
[16] K. Sneppen,et al. Theoretical Analysis of Epigenetic Cell Memory by Nucleosome Modification , 2007, Cell.
[17] V. Uversky,et al. Methionine oxidation, a-synuclein and Parkinson's disease , 2005 .
[18] A. Ciechanover,et al. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. , 2002, Physiological reviews.
[19] N. Gonatas,et al. Effect of ubiquitin expression on neuropathogenesis in a mouse model of familial amyotrophic lateral sclerosis , 2005, Neuropathology and applied neurobiology.
[20] Peter T. Lansbury,et al. Kinetic Stabilization of the α-Synuclein Protofibril by a Dopamine-α-Synuclein Adduct , 2001, Science.
[21] E. Stadtman,et al. Oxidation of free amino acids and amino acid residues in proteins by radiolysis and by metal-catalyzed reactions. , 1993, Annual review of biochemistry.
[22] V. Subramaniam,et al. NMR of α‐synuclein–polyamine complexes elucidates the mechanism and kinetics of induced aggregation , 2004, The EMBO journal.
[23] T. Zglinicki,et al. Protein oxidation and degradation during proliferative senescence of human MRC-5 fibroblasts. , 2000, Free radical biology & medicine.
[24] Aaron Ciechanover,et al. The Ubiquitin Proteasome System in Neurodegenerative Diseases Sometimes the Chicken, Sometimes the Egg , 2003, Neuron.
[25] Theodore W Randolph,et al. Oxidative dimer formation is the critical rate-limiting step for Parkinson's disease alpha-synuclein fibrillogenesis. , 2003, Biochemistry.
[26] P. Lansbury,et al. Vesicle permeabilization by protofibrillar alpha-synuclein: implications for the pathogenesis and treatment of Parkinson's disease. , 2001, Biochemistry.
[27] V. Uversky,et al. Nitration inhibits fibrillation of human α‐synuclein in vitro by formation of soluble oligomers , 2003 .
[28] K. Sneppen,et al. Time delay as a key to apoptosis induction in the p53 network , 2002, cond-mat/0207236.
[29] J. Langston,et al. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. , 1983, Science.
[30] Peter T. Lansbury,et al. Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease , 1998, Nature Medicine.
[31] Jeremy N. Skepper,et al. α-Synuclein Is Degraded by Both Autophagy and the Proteasome* , 2003, Journal of Biological Chemistry.
[32] Robert Burke,et al. Resistance of α-synuclein null mice to the parkinsonian neurotoxin MPTP , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[33] K. Tanaka,et al. Half-life of proteasomes (multiprotease complexes) in rat liver. , 1989, Biochemical and biophysical research communications.
[34] H. Pakkenberg,et al. MPTP-induced Parkinsonism in minipigs: A behavioral, biochemical, and histological study. , 1999, Neurotoxicology and teratology.
[35] V. Uversky,et al. Evidence for a Partially Folded Intermediate in α-Synuclein Fibril Formation* , 2001, The Journal of Biological Chemistry.
[36] David W. Miller,et al. Motor dysfunction and gliosis with preserved dopaminergic markers in human α-synuclein A30P transgenic mice , 2003, Neurobiology of Aging.
[37] Andrew B West,et al. Molecular pathophysiology of Parkinson's disease. , 2005, Annual review of neuroscience.
[38] K Sneppen,et al. Thermodynamics of heat-shock response. , 1999, Physical review letters.
[39] B. Friguet,et al. Increase of oxidatively modified protein is associated with a decrease of proteasome activity and content in aging epidermal cells. , 2000, The journals of gerontology. Series A, Biological sciences and medical sciences.
[40] C. Marsden,et al. Age-related effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment of common marmosets. , 1993, European journal of pharmacology.
[41] Armin Giese,et al. Different Species of α-Synuclein Oligomers Induce Calcium Influx and Seeding , 2007, The Journal of Neuroscience.
[42] K Tanaka,et al. Structure and functions of the 20S and 26S proteasomes. , 1996, Annual review of biochemistry.
[43] Robert L. Nussbaum,et al. Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .
[44] V. Uversky,et al. Heparin and other glycosaminoglycans stimulate the formation of amyloid fibrils from alpha-synuclein in vitro. , 2002, Biochemistry.
[45] K. Chung,et al. Dequalinium-induced Protofibril Formation of α-Synuclein* , 2006, Journal of Biological Chemistry.
[46] C. Ross,et al. Inducible expression of mutant alpha-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis. , 2001, Human molecular genetics.
[47] A. Cuervo,et al. Degradation of proteasomes by lysosomes in rat liver. , 1995, European journal of biochemistry.
[48] A. Goldberg,et al. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules , 1994, Cell.
[49] V. Uversky,et al. Conformational behavior and aggregation of alpha-synuclein in organic solvents: modeling the effects of membranes. , 2003, Biochemistry.
[50] Kostas Vekrellis,et al. Wild Type α-Synuclein Is Degraded by Chaperone-mediated Autophagy and Macroautophagy in Neuronal Cells* , 2008, Journal of Biological Chemistry.
[51] Kim Sneppen,et al. Ultrasensitive gene regulation by positive feedback loops in nucleosome modification , 2008, Molecular systems biology.
[52] Jeff Kuret,et al. Rapid Anionic Micelle-mediated α-Synuclein Fibrillization in Vitro* , 2003, Journal of Biological Chemistry.
[53] C. Deocaris,et al. Proteasomal Oscillation during Mild Heat Shock in Aging Human Skin Fibroblasts , 2006, Annals of the New York Academy of Sciences.
[54] Peter T. Lansbury,et al. Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy , 2004, Science.
[55] J. Paramio,et al. Changes in proteasome localization during the cell cycle. , 1994, European journal of cell biology.
[56] C. K. Lee,et al. Gene expression profile of aging and its retardation by caloric restriction. , 1999, Science.
[57] C. Dobson,et al. Molecular determinants of the aggregation behavior of α‐ and β‐synuclein , 2008, Protein science : a publication of the Protein Society.
[58] P. Lockhart,et al. Parkin Protects against the Toxicity Associated with Mutant α-Synuclein Proteasome Dysfunction Selectively Affects Catecholaminergic Neurons , 2002, Neuron.
[59] P. Lansbury,et al. Alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils. , 2002, Journal of molecular biology.
[60] Hidefumi Ito,et al. Immunocytochemical Co‐localization of the Proteasome in Ubiquitinated Structures in Neurodegenerative Diseases and the Elderly , 1997, Journal of neuropathology and experimental neurology.
[61] L. Forno,et al. Neuropathology of Parkinson's Disease , 1996, Journal of neuropathology and experimental neurology.
[62] L. Regan,et al. A general model for amyloid fibril assembly based on morphological studies using atomic force microscopy. , 2003, Biophysical journal.
[63] William E. Balch,et al. An Adaptable Standard for Protein Export from the Endoplasmic Reticulum , 2007, Cell.
[64] N. Chondrogianni,et al. Proteasome inhibition induces a senescence-like phenotype in primary human fibroblasts cultures , 2004, Biogerontology.
[65] Sandeep Krishna,et al. Oscillation patterns in negative feedback loops , 2006, Proceedings of the National Academy of Sciences.
[66] V. Uversky,et al. Methionine oxidation inhibits fibrillation of human α‐synuclein in vitro , 2002 .
[67] Tobias Jung,et al. Oxidized proteins: intracellular distribution and recognition by the proteasome. , 2007, Archives of biochemistry and biophysics.
[68] M. Spillantini,et al. α‐Synuclein metabolism and aggregation is linked to ubiquitin‐independent degradation by the proteasome , 2001, FEBS letters.
[69] J. Ferrell. Self-perpetuating states in signal transduction: positive feedback, double-negative feedback and bistability. , 2002, Current opinion in cell biology.
[70] K. Sneppen,et al. Minimal model of spiky oscillations in NF-κB signaling , 2006 .
[71] L. Mucke,et al. Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. , 2000, Science.
[72] P. Lansbury,et al. Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[73] Philippe Amouyel,et al. α-synuclein locus duplication as a cause of familial Parkinson's disease , 2004, The Lancet.
[74] John Q. Trojanowski,et al. Induction of α-Synuclein Aggregation by Intracellular Nitrative Insult , 2001, The Journal of Neuroscience.
[75] A. Goldberg,et al. PAN, the proteasome-activating nucleotidase from archaebacteria, is a protein-unfolding molecular chaperone , 2000, Nature Cell Biology.
[76] R. Kopito,et al. Impairment of the ubiquitin-proteasome system by protein aggregation. , 2001, Science.
[77] B. Friguet,et al. Inhibition of the multicatalytic proteinase (proteasome) by 4‐hydroxy‐2‐nonenal cross‐linked protein , 1997, FEBS letters.